187 related articles for article (PubMed ID: 26750604)
1. Reprogramming and Stemness.
Laplane L
Perspect Biol Med; 2015; 58(2):229-46. PubMed ID: 26750604
[TBL] [Abstract][Full Text] [Related]
2. Primitive Cancer Cell States: A Target for Drug Screening?
Wan ACA
Trends Pharmacol Sci; 2019 Mar; 40(3):161-171. PubMed ID: 30709543
[TBL] [Abstract][Full Text] [Related]
3. [The identity of normal and cancer stem cells].
Laplane L; Solary É
Med Sci (Paris); 2017 Oct; 33(10):899-904. PubMed ID: 28994387
[TBL] [Abstract][Full Text] [Related]
4. Emerging Mechanisms by which EMT Programs Control Stemness.
Wilson MM; Weinberg RA; Lees JA; Guen VJ
Trends Cancer; 2020 Sep; 6(9):775-780. PubMed ID: 32312682
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells and differentiation therapy.
Sell S
Tumour Biol; 2006; 27(2):59-70. PubMed ID: 16557043
[TBL] [Abstract][Full Text] [Related]
6. Stem cell origin of cancer and differentiation therapy.
Sell S
Crit Rev Oncol Hematol; 2004 Jul; 51(1):1-28. PubMed ID: 15207251
[TBL] [Abstract][Full Text] [Related]
7. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis.
Kuhn NZ; Tuan RS
J Cell Physiol; 2010 Feb; 222(2):268-77. PubMed ID: 19847802
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Cellular Identity in Cancer.
Roy N; Hebrok M
Dev Cell; 2015 Dec; 35(6):674-84. PubMed ID: 26702828
[TBL] [Abstract][Full Text] [Related]
9. Q&A: John Dick on stem cells and cancer.
Dick J
Cancer Discov; 2013 Feb; 3(2):131. PubMed ID: 23400460
[No Abstract] [Full Text] [Related]
10. Physiological cellular reprogramming and cancer.
Abollo-Jiménez F; Jiménez R; Cobaleda C
Semin Cancer Biol; 2010 Apr; 20(2):98-106. PubMed ID: 20188173
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
12. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
Shah M; Allegrucci C
Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
[TBL] [Abstract][Full Text] [Related]
13. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells: the development of new cancer therapeutics.
Scatena R; Bottoni P; Pontoglio A; Giardina B
Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
[TBL] [Abstract][Full Text] [Related]
15. Common themes of dedifferentiation in somatic cell reprogramming and cancer.
Daley GQ
Cold Spring Harb Symp Quant Biol; 2008; 73():171-4. PubMed ID: 19150965
[TBL] [Abstract][Full Text] [Related]
16. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
Kim JJ; Rai R
Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms promoting physiological cells progression into tumorigenesis.
Korbut E; Ptak-Belowska A; Brzozowski T
J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitylating enzymes as cancer stem cell therapeutics.
Haq S; Suresh B; Ramakrishna S
Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):1-10. PubMed ID: 29054474
[TBL] [Abstract][Full Text] [Related]
19. The stem cell niche in health and malignancy.
Burness ML; Sipkins DA
Semin Cancer Biol; 2010 Apr; 20(2):107-15. PubMed ID: 20510363
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Therapeutic Implications of Cancer Stem Cells.
Clarke MF
N Engl J Med; 2019 Jun; 380(23):2237-2245. PubMed ID: 31167052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
